Benzinga | Jan 19, 2021 09:00AM EST

Document Security Systems Subsidiary Impact BioMedical Enters Investment And Distribution Agreement With Nano9 Labs

ROCHESTER, N.Y., Jan. 19, 2021 (GLOBE NEWSWIRE) -- Document Security Systems, Inc. ("DSS" or the "Company") (NYSE:DSS), a multinational company operating businesses focusing on brand protection technology, blockchain security, direct marketing, healthcare, real estate, and securitized digital assets, today announced its wholly owned subsidiary Impact BioMedical, Inc. ("Impact BioMedical") entered into an investment and distribution agreement with Nano9 Labs, LLC ("Nano9"), an R&D and contract manufacturing company specializing in the development of nano-sized nutraceutical products and ingredients.